share_log

ProSomnus | POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filing

SEC announcement ·  Feb 5 12:02
Summary by Moomoo AI
On February 2, 2024, ProSomnus, Inc., a Delaware corporation, filed a post-effective amendment to its Form S-1 on Form S-3 with the Securities and Exchange Commission (SEC). This amendment is intended to convert the original registration statement into a registration statement on Form S-3 and to remove from registration the Convertible Note Shares that were previously registered, of which 230,494 have been sold. The company is also preparing for the primary offering of up to 6,512,087 shares of common stock upon the exercise of warrants, and a secondary offering of up to 9,850,363 shares of common stock and up to 2,411,848 warrants. ProSomnus, Inc. is known for manufacturing precision, mass-customized oral appliance therapy devices to treat obstructive sleep apnea. The company's common stock...Show More
On February 2, 2024, ProSomnus, Inc., a Delaware corporation, filed a post-effective amendment to its Form S-1 on Form S-3 with the Securities and Exchange Commission (SEC). This amendment is intended to convert the original registration statement into a registration statement on Form S-3 and to remove from registration the Convertible Note Shares that were previously registered, of which 230,494 have been sold. The company is also preparing for the primary offering of up to 6,512,087 shares of common stock upon the exercise of warrants, and a secondary offering of up to 9,850,363 shares of common stock and up to 2,411,848 warrants. ProSomnus, Inc. is known for manufacturing precision, mass-customized oral appliance therapy devices to treat obstructive sleep apnea. The company's common stock and public warrants are listed on the Nasdaq Global Market and Nasdaq Capital Market under the symbols 'OSA' and 'OSAAW', respectively. The closing prices for the common stock and public warrants as of January 29, 2024, were $0.82 and $0.035, respectively. ProSomnus has declared itself as an 'emerging growth company' and a 'smaller reporting company', which may allow it to comply with reduced public company reporting requirements for this and future filings.

This announcement is a separate document:

Doc 1

Doc 2

Doc 3

Doc 4

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more